Literature DB >> 17127399

Cell dynamics and immune response to BLV infection: a unifying model.

Arnaud Florins1, Nicolas Gillet, Becca Asquith, Mathieu Boxus, Catherine Burteau, Jean-Claude Twizere, Patrice Urbain, Fabian Vandermeers, Christophe Debacq, Maria Teresa Sanchez-Alcaraz, Isabelle Schwartz-Cornil, Pierre Kerkhofs, Genèvieve Jean, Andre Théwis, Jack Hay, Franck Mortreux, Eric Wattel, Michal Reichert, Arsène Burny, Richard Kettmann, Charles Bangham, Luc Willems.   

Abstract

Bovine Leukemia virus (BLV) is the natural etiological agent of a lymphoproliferative disease in cattle. BLV can also be transmitted experimentally to a related ruminant species, sheep, in which the pathogenesis is more acute. Although both susceptible species develop a strong anti-viral immune response, the virus persists indefinitely throughout life, apparently at a transcriptionally silent stage, at least in a proportion of infected cells. Soon after infection, these humoral and cytotoxic activities very efficiently abolish the viral replicative cycle, permitting only mitotic expansion of provirus-carrying cells. Short term cultures of these infected cells initially indicated that viral expression protects against spontaneous apoptosis, suggesting that leukemia is a process of accumulation of long-lived cells. This conclusion was recently reconsidered following in vivo dynamic studies based on perfusions of nucleoside (bromodeoxyuridine) or fluorescent protein markers (CFSE). In sheep, the turnover rate of infected cells is increased, suggesting that a permanent clearance process is exerted by the immune system. Lymphocyte trafficking from and to the secondary lymphoid organs is a key component in the maintenance of cell homeostasis. The net outcome of the immune selective pressure is that only cells in which the virus is transcriptionally silenced survive and accumulate, ultimately leading to lymphocytosis. Activation of viral and/or cellular expression in this silent reservoir with deacetylase inhibitors causes the collapse of the proviral loads. In other words, modulation of viral expression appears to be curative in lymphocytic sheep, an approach that might also be efficient in patients infected with the related Human T-lymphotropic virus type 1. In summary, a dynamic interplay between BLV and the host immune response modulates a complex equilibrium between (i) viral expression driving (or) favoring proliferation and (ii) viral silencing preventing apoptosis. As conclusion, we propose a hypothetical model unifying all these mechanisms.

Entities:  

Mesh:

Year:  2007        PMID: 17127399     DOI: 10.2741/2165

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  28 in total

1.  Interaction between Bovine leukemia virus (BLV) infection and age on telomerase misregulation.

Authors:  Farhid Hemmatzadeh; Hadi Keyvanfar; Noor Haliza Hasan; Faustina Niap; Ebrahim Bani Hassan; Azar Hematzade; Esmaeil Ebrahimie; Andrea McWhorter; Jagoda Ignjatovic
Journal:  Vet Res Commun       Date:  2015-02-11       Impact factor: 2.459

2.  Spleen-dependent turnover of CD11b peripheral blood B lymphocytes in bovine leukemia virus-infected sheep.

Authors:  Arnaud Florins; Nicolas Gillet; Becca Asquith; Christophe Debacq; Geneviève Jean; Isabelle Schwartz-Cornil; Michel Bonneau; Arsène Burny; Michal Reichert; Richard Kettmann; Luc Willems
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

3.  Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.

Authors:  Rashade A H Haynes; Evan Ware; Christopher Premanandan; Bevin Zimmerman; Lianbo Yu; Andrew J Phipps; Michael D Lairmore
Journal:  Blood       Date:  2009-11-20       Impact factor: 22.113

Review 4.  Can Bovine Leukemia Virus Be Related to Human Breast Cancer? A Review of the Evidence.

Authors:  Lucia Martinez Cuesta; Pamela Anahi Lendez; Maria Victoria Nieto Farias; Guillermina Laura Dolcini; Maria Carolina Ceriani
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-05-18       Impact factor: 2.673

5.  Even attenuated bovine leukemia virus proviruses can be pathogenic in sheep.

Authors:  Arnaud Florins; Nicolas Gillet; Mathieu Boxus; Pierre Kerkhofs; Richard Kettmann; Luc Willems
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

6.  BLV-CoCoMo-qPCR: a useful tool for evaluating bovine leukemia virus infection status.

Authors:  Mayuko Jimba; Shin-Nosuke Takeshima; Hironobu Murakami; Junko Kohara; Naohiko Kobayashi; Tamako Matsuhashi; Takashi Ohmori; Tetsuo Nunoya; Yoko Aida
Journal:  BMC Vet Res       Date:  2012-09-21       Impact factor: 2.741

Review 7.  Molecular determinants of human T-lymphotropic virus type 1 transmission and spread.

Authors:  Michael D Lairmore; Rajaneesh Anupam; Nadine Bowden; Robyn Haines; Rashade A H Haynes; Lee Ratner; Patrick L Green
Journal:  Viruses       Date:  2011-07-12       Impact factor: 5.048

8.  Differential role of PKC-induced c-Jun in HTLV-1 LTR activation by 12-O-tetradecanoylphorbol-13-acetate in different human T-cell lines.

Authors:  Ammar Abou-Kandil; Rachel Chamias; Mahmoud Huleihel; W T Godbey; Mordechai Aboud
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

9.  Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium.

Authors:  Fabiola Martin; Charles R M Bangham; Vincenzo Ciminale; Michael D Lairmore; Edward L Murphy; William M Switzer; Renaud Mahieux
Journal:  Retrovirology       Date:  2011-10-28       Impact factor: 4.602

10.  Bovine leukemia virus p24 antibodies reflect blood proviral load.

Authors:  Gerónimo Gutiérrez; Hugo Carignano; Irene Alvarez; Cecilia Martínez; Natalia Porta; Romina Politzki; Mariela Gammella; Marina Lomonaco; Norberto Fondevila; Mario Poli; Karina Trono
Journal:  BMC Vet Res       Date:  2012-10-09       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.